Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022

SELL
$4.65 - $7.37 $27,314 - $43,291
-5,874 Reduced 7.66%
70,827 $343,000
Q2 2022

Aug 11, 2022

SELL
$4.21 - $11.15 $235,806 - $624,522
-56,011 Reduced 42.2%
76,701 $354,000
Q1 2022

May 16, 2022

SELL
$8.48 - $18.1 $139,835 - $298,469
-16,490 Reduced 11.05%
132,712 $1.43 Million
Q4 2021

Feb 09, 2022

BUY
$15.37 - $22.5 $2.29 Million - $3.36 Million
149,202 New
149,202 $2.55 Million

Others Institutions Holding TIL

About Instil Bio, Inc.


  • Ticker TIL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 129,694,000
  • Market Cap $2.82B
  • Description
  • Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of patients with cancer. The company develops cell therapy of autologous tumor infiltrating lymphocyte (TIL). Its TIL product candidates in pipeline include ITIL-168 for indications, such as melanoma, cutaneous squamous cell carcinoma, non-small ce...
More about TIL
Track This Portfolio

Track Alps Advisors Inc Portfolio

Follow Alps Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alps Advisors Inc, based on Form 13F filings with the SEC.

News

Stay updated on Alps Advisors Inc with notifications on news.